Piperazine Citrate Anhydrous

CHEMBL3990694 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
642.7 g/mol
LogP
Phase
4

Piperazine citrate anhydrous is the anhydrous citrate salt form of piperazine, an anthelmintic that causes flaccid paralysis of intestinal nematodes through GABA-mimetic activity at worm muscle membranes. See piperazine for complete pharmacological details.

分子量

642.7000 g/mol

TPSA

336.00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C1CNCCN1.C1CNCCN1.C1CNCCN1.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O

InChI

InChI=1S/2C6H8O7.3C4H10N2/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;3*1-2-6-4-3-5-1/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);3*5-6H,1-4H2

Molecular Formula

C24H46N6O14

HBD / HBA

14 / 20

可旋转键数

10

重原子数

44

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

Piperazine citrate anhydrous is the anhydrous citrate salt form of piperazine, an anthelmintic that causes flaccid paralysis of intestinal nematodes through GABA-mimetic activity at worm muscle membranes. See piperazine for complete pharmacological details.

Yes, Piperazine Citrate Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3990694. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 15595021. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.